Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp

Bullboard Posts

Comment by slaveonfoolson Aug 08, 2013 7:27pm

156 Views

Post# 21658014

RE:added more

I agree with you wj except in regards to pp paper...there hasn't been much opportunity yet for them to sell as we haven't really made a significant move in stock price to give them an opportunity to sell. Not saying they will and I know some that are involved in pp and will def not be selling anytime soon. The test will be more around/above 15c to see if those shares are in tight hands or not. We know Chris Verrico holds 1.5m of the pp so that should be in safe hands

Bullboard Posts

Paramount Resources signs $3.32 billion asset sale